Takatoshi Soga

Company: United Immunity Co. Ltd.

Job title: SVP

Seminars:

A next generation PEG-free LNP technology that actively targets myeloid cells through selective binding to the myeloid lectin DC-SIGN receptor 11:45 am

Pullulan LNPs are PEG-free and selectively targets macrophages and dendritic cells through specific binding to the C-type lectin receptor DC-SIGN. PEG-free Pullulan LNP could avoid PEG-dependent undesirable reactions such as allergy, anaphylaxis, and accelerated blood clearance Pullulan LNPs are ideal for tumor environment modulation, cancer vaccines, and infectious disease vaccinesRead more

day: Conference Day Two